🇺🇸 FDA
Patent

US 7999079

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

granted A61KA61K2039/507A61P

Quick answer

US patent 7999079 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/507, A61P, A61P31/04, A61P39/00